Sanford Guide ID Update features current developments in infectious diseases, curated by the Sanford Guide Editorial Board. Links marked with an asterisk (*) provide details to Web Edition subscribers, while all other links are universal. To sign up for ID updates to your inbox, register here.
2021 Sanford Guides Available
- 2021 editions of The Sanford Guide to Antimicrobial Therapy are now available for immediate shipping from the Sanford Guide Store. This year's books include a 1-month trial of our digital editions.
SARS-CoV-2 / COVID-19
Sanford Guide SARS-CoV-2 / COVID-19 material is freely available to all for the course of the pandemic.
- CDC: Updated interim public health recommendations for fully vaccinated people here.
- Currently authorized vaccines. See COVID-19 Prevention for table summarizing use and data.
- May 10: the US FDA expanded the EUA for the Pfizer-BioNTech COVID-19 vaccine to include adolescents 12 through 15 years of age. Full FDA news release here.
- COVID-19 vaccination in cancer patients: preliminary recommendations from NCCN here.
- Guidelines on COVID-19 diagnosis, serology, treatment and management, and infection prevention: IDSA and NIH.
- Living WHO guideline on drugs for COVID-19 (BMJ 2020;370:m3379). Available here.
- Living WHO guideline on drugs to prevent COVID-19 (BMJ 2021;372:n526). Available here.
- Living WHO guideline on prophylaxis against COVID-19 (BMJ 2021;373:n949). Available at PMC.
- Management of hospitalized adults with COVID-19: a European Respiratory Society living guideline (Eur Respir J 2021 Mar 10 [Epub ahead of print]). Available at PMC.
New or Updated Treatment Guidelines
- 2021 clinical guidelines for the diagnosis and treatment of botulism (MMWR Recomm Rep 2021;70(2):1-30). The guidelines are available here.
- Clinical practice guidelines for nucleic acid-based testing for noninfluenza viral pathogens in adults with suspected community-acquired pneumonia, from the American Thoracic Society (Am J Respir Crit Care Med 2021;203:1070). The guidelines are available here.
- 2020 updated guidelines for primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors, from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (Ann Hematol 2021 Apr 13 [online ahead of print]). The guidelines were last updated in 2013. Available here.
Drug Shortages (US)
- Antimicrobial drugs or vaccines in reduced supply or unavailable (as of May 9, 2021) due to increased demand, manufacturing delays, product discontinuation by a specific manufacturer, or unspecified reasons:
- New on the list since April 11, 2021: None
- Shortage recently resolved: Cefoxitin injection, Ethambutol tablets, Tobramycin lyophilized powder for injection
- Antibacterial drugs in continued reduced supply:
- Aminoglycosides: Amikacin injection, Gentamicin injection, Tobramycin injection
- Carbapenems: Meropenem injection
- Cephalosporins: Cefazolin injection, Cefepime injection, Cefotaxime injection (FDA is allowing temporary importation of product from SteriMax in Canada, in conjunction with Apollo Pharmaceuticals and its distributor FFF Enterprises. Click here for details), Cefotetan injection, Ceftazidime injection, Ceftazidime-avibactam injection, Ceftolozane-tazobactam injection
- Clindamycin injection
- Fluoroquinolones: Ciprofloxacin 0.3% ophthalmic solution, Gemifloxacin tablets
- Glycopeptides, glycolipopeptides, lipopeptides: Vancomycin injection
- Macrolides/azalides: Azithromycin injection, Azithromycin ophthalmic solution 1% (unavailable)
- Methanamine hippurate tablets
- Nitrofurantoin oral suspension
- Penicillins: Ampicillin-sulbactam injection, Piperacillin-tazobactam injection
- Tetracyclines: None
- Topical (miscellaneous) antibacterials: Neomycin and Polymyxin B sulfates GU irrigant, Neomycin and Polymyxin B sulfates and Dexamethasone ophthalmic ointment, Sulfacetamide 10%/Prednisolone 0.2% ophthalmic ointment (unavailable), Sulfanilamide 15% vaginal cream (unavailable)
- Antimycobacterial drugs
- Rifampin injection
- Antifungal, antiparasitic, and antiviral drugs in continued reduced supply:
- Antifungal drugs: Clotrimazole 10 mg oral troches
- Antiparasitic drugs: Chloroquine tablets, Hydroxychloroquine tablets
- Antiviral drugs: Acyclovir injection, Cidofovir injection
- Vaccines in continued reduced supply:
- Hepatitis B vaccine recombinant, Yellow Fever vaccine (YF-VAX is scheduled for re-launch in the US during the week of April 5).
- Antimicrobial drugs recently discontinued:
- Mupirocin calcium 2% cream (Bactroban [GSK], in June 2020), Bacitracin injection (in February 2020), Interferon alfa-2b (Intron A, in October 2019), Mupirocin calcium 2% nasal ointment (Bactroban Nasal [GSK], in August 2019), Quinidine gluconate IV (in December 2017), Terbinafine granules (in May 2017), MenHibrix (in February 2017), Elvitegravir (Vitekta, in December 2016), Peginterferon alfa-2b (in February 2016; 50 mcg vials still available in limited quantities), Boceprevir (in December 2015), Permethrin 1% topical lotion (in September 2015).
- For more detailed information including estimated resupply dates, see https://www.ashp.org/Drug-Shortages/